real-time news and commentary for investors
Thursday, Jul 4
GlaxoSmithKline (GSK), whose staff are being investigated for possible economic crimes in China,...
GlaxoSmithKline (GSK), whose staff are being investigated for possible economic crimes in China, could be in more trouble in the country. The U.K. pharmaceuticals giant is reportedly caught up in a price-fixing probe of 60 foreign companies and 10 China-listed firms by the National Development & Reform Commission (NDRC). The investigation could home in on price differences in China and abroad for imported products. It emerged earlier this week that the NDRC is investigating possible price fixing in the baby milk-formula market.